Australia markets close in 2 hours 23 minutes

Starpharma Holdings Limited (SPL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.1700-0.0200 (-1.68%)
As of 4:10PM AEDT. Market open.
Currency in AUD

Valuation measures

Market cap (intra-day) 5485.45M
Enterprise value 3426.12M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)263.77
Price/book (mrq)7.79
Enterprise value/revenue 3237.00
Enterprise value/EBITDA 7-19.89

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-20.95%
S&P500 52-week change 330.48%
52-week high 32.5200
52-week low 31.1300
50-day moving average 31.2854
200-day moving average 31.4997

Share statistics

Avg vol (3-month) 3588.16k
Avg vol (10-day) 3571.74k
Shares outstanding 5406.24M
Implied shares outstanding 6N/A
Float 8377.67M
% held by insiders 16.67%
% held by institutions 149.87%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 425 Mar 1988
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)30 June 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-979.45%

Management effectiveness

Return on assets (ttm)-23.45%
Return on equity (ttm)-42.15%

Income statement

Revenue (ttm)2.15M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)71.00%
Gross profit (ttm)-13.71M
EBITDA -20.77M
Net income avi to common (ttm)-19.73M
Diluted EPS (ttm)-0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)60.5M
Total cash per share (mrq)0.15
Total debt (mrq)1.17M
Total debt/equity (mrq)1.87
Current ratio (mrq)6.78
Book value per share (mrq)0.15

Cash flow statement

Operating cash flow (ttm)-14.81M
Levered free cash flow (ttm)-8.73M